Applied Molecular Transport Inc. (AMTI)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Tahir Mahmood
Employees:
120
1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO, CA 94080
650-392-0420

Applied Molecular Transport Inc. engages in the design and development of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis.

Data derived from most recent annual or quarterly report
Market Cap 70.737 Million Shares Outstanding38.654 Million Avg 30-day Volume 322.822 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.2
Price to Revenue0.0 Debt to Equity0.0013 EBITDA-131.87 Million
Price to Book Value1.1535 Operating Margin0.0 Enterprise Value17.054 Million
Current Ratio6.25 EPS Growth-2.723 Quick Ratio5.912
1 Yr BETA 1.9023 52-week High/Low 33.28 / 1.71 Profit Margin0.0
Operating Cash Flow Growth-34.9779 Altman Z-Score-3.9971 Free Cash Flow to Firm -88.173 Million
Earnings Report2022-11-09
View SEC Filings from AMTI instead.

View recent insider trading info

Funds Holding AMTI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AMTI

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-06:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-27:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-18:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-25:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-04-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-02-11:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-01-28:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    RICH DOUGLAS A. CHIEF TECHNICAL OFFICER

    • Officer
    54,475 2022-06-01 3

    CROSS SHAWN PRESIDENT & COO

    • Officer
    133,850 2022-06-01 4

    HANTS BRANDON CFO

    • Officer
    33,263 2022-06-01 4

    MRSNY RANDALL PH.D.

    • Director
    3,640,470 2022-06-01 4

    MAHMOOD TAHIR PH.D. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    3,674,925 2022-06-01 3

    KANWAR BITTOO CHIEF MEDICAL OFFICER

    • Officer
    80,612 2022-06-01 4

    SMITHER JOHN W

    • Director
    20,000 2022-05-24 3

    LAMOND DAVID

    • Director
    20,000 2022-05-24 2

    VANDEVENDER AARON

    • Director
    20,000 2022-05-24 2

    SCHACHNER HOLLY CAREN

    • Director
    20,000 2022-05-24 3

    BANARD CHARLENE A.

    • Director
    20,000 2022-05-24 3

    EPIQ CAPITAL GROUP, LLC

    EPQ LLC AMT PS

    EPQ LLC, AMTB PS

    EPQ LLC, AMTC PS

    BOEDING CHAD

    • MANAGING MEMBER OF 10% OWNEROWNEROWNEROWNERCEO OF MANAGING MEMBER
    8,337,518 2022-05-12 2

    BHATT ELIZABETH CHIEF BUS. & STRATEGY OFFICER

    • Officer
    129,250 2022-02-15 2

    COOPER GRAHAM K

    • Director
    300,000 2022-01-27 1

    EPIQ CAPITAL GROUP, LLC

    EPQ LLC AMT PS

    EPQ LLC, AMTB PS

    EPQ LLC, AMTC PS

    • 10% Owner
    • MANAGING MEMBER OF 10% OWNEROWNER OWNER
    8,275,375 2021-11-16 2

    KIM HELEN SUSAN

    • Director
    575,000 2021-08-26 2

    FOUNDERS FUND V, LP

    FOUNDERS FUND V ENTREPRENEURS FUND, LP

    FOUNDERS FUND V PRINCIPALS FUND, LP

    FOUNDERS FUND VI, LP

    FOUNDERS FUND VI ENTREPRENEURS FUND, LP

    FOUNDERS FUND VI PRINCIPALS FUND, LP

    • 10% Owner
    4,438,222 2020-06-09 0

    EPIQ CAPITAL GROUP, LLC

    EPQ LLC AMT PS

    EPQ LLC, AMTB PS

    • 10% Owner
    • MANAGING MEMBER OF 10% OWNER
    5,544,240 2020-06-04 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 22:15:04 UTC 0.9544 1.3656 90000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 21:45:04 UTC 0.9544 1.3656 90000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 21:15:04 UTC 0.9544 1.3656 90000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 20:45:04 UTC 0.9544 1.3656 90000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 20:15:04 UTC 0.9544 1.3656 90000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 19:45:04 UTC 0.9544 1.3656 90000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 19:15:04 UTC 0.9544 1.3656 90000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 18:45:04 UTC 1.0204 1.2996 90000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 18:15:05 UTC 1.0204 1.2996 90000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 17:45:04 UTC 1.0204 1.2996 90000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 17:15:04 UTC 1.0204 1.2996 90000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 16:45:04 UTC 1.0364 1.2836 90000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 16:15:03 UTC 1.0364 1.2836 95000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 15:45:04 UTC 1.0364 1.2836 100000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 15:15:05 UTC 1.0364 1.2836 70000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 14:45:04 UTC 1.0364 1.2836 70000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 14:15:05 UTC 1.0364 1.2836 70000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 13:45:04 UTC 1.052 1.268 70000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 13:15:04 UTC 1.052 1.268 70000
    APPLIED MOLECULAR TRANSPORT AMTI 2022-08-18 12:45:05 UTC 1.052 1.268 70000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund AMTI -5879.0 shares, $-44210.08 2022-03-31 N-PORT

    Elevate your investments